Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-A nationwide population-based study

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Liu, Chia Chu ^a,b,c   Hsieh, Hui Min ^d   Wu, Chia Fang ^d   Hsieh, Tusty Jiuan ^a   Huang, Shu Pin ^a,b   Chou, Yii Her ^a,b   Huang, Chun Nung ^a,b   Wu, Wen Jeng ^a,b   Wu, Ming Tsang ^b,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Pingtung Hospital   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; DRUG EXPOSURE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LITHOTRIPSY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; TAIWAN; TREATMENT DURATION; URETERORENOSCOPIC LITHOTRIPSY; UROLITHIASIS; UROLOGIC SURGERY; YOUNG ADULT; CASE CONTROL STUDY; KIDNEY CALCULI; PATHOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MALE; MIDDLE AGED; RECURRENCE; TAIWAN; UROLITHIASIS;

EID: 84929458928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122494     Document Type: Article

References (28)

1. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 2006; 367:333-44. PMID: 16443041
2. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 2010; 12:e86-96. PMID: 20811557
3. Cupisti A. Update on nephrolithiasis: beyond symptomatic urinary tract obstruction. J Nephrol 2011; 24 Suppl 18:S25-9. doi: 10.5301/JN.2011.7766 PMID: 21623579
4. Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 2002; 68:172-7. PMID: 11919463
5. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med 2010; 363:954-63. doi: 10.1056/NEJMcp1001011 PMID: 20818905
6. Brown J. Diagnostic and treatment patterns for renal colic in US emergency departments. Int Urol Nephrol 2006; 38:87-92. PMID: 16502058
7. Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 2005; 68:1808-14. PMID: 16164658
8. Moe OW, Pearle MS, Sakhaee K. Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int 2011; 79:385-92. doi: 10.1038/ki.2010.389 PMID: 20927039
9. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 2009; 56:455-71. doi: 10.1016/j.eururo.2009.06.012 PMID: 19560860
10. Zhu Y, Duijvesz D, Rovers MM, Lock TM. Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int 2010; 106:256-61. doi: 10.1111/j.1464-410X.2009.09014.x PMID: 19889063
11. Karabacak OR, Yilmazer D, Ozturk U, Sener NC, Saltas H, Karabacak Y, et al. The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces. Urolithiasis. 2013; 41(5): 385-8. doi: 10.1007/s00240-013-0592-5 PMID: 23877383
12. National Health Insurance Research Database, National Health Research Institutes. 2012. Available: http://nhird.nhri.org.tw/en/index.htm. Accessed 06 June 2013.
13. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). US Centers for Diseases Control and Prevention., 2012. Available: http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed 06 June 2013.
14. Huang CY, Chen SS, Chen LK. Cost-effectiveness of treating ureteral stones in a Taipei City Hospital: shock wave lithotripsy versus ureteroscopy plus lithoclast. Urol Int 2009; 83:410-5. doi: 10.1159/000251180 PMID: 19996647
15. Lee YH, Tsai JY, Jiaan BP, Wu T, Yu CC. Prospective randomized trial comparing shock wave lithotripsy and ureteroscopic lithotripsy for management of large upper third ureteral stones. Urology 2006; 67:480-4 PMID: 16527562
16. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003; 158:915-20. PMID: 14585769
17. Suissa S. Immortal Time Bias in Observational Studies of drug effects. Pharmacoepidemiol Drug Safety. 2007; 16: 241-9.
18. Richardson DB. An incidence density sampling program for nested case-control analysis. Occup Environ Med, 2004; 61, e59: pp1-5. PMID: 15550597
19. WHO. WHO collaborating Center for Drugs Statistics Methodology: ATC Index with DDDs. Oslo, Norway, WHO.; 2003. PMID: 17875031
20. Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 2005; 24:142-8. PMID: 15690361
21. Tomiyama Y, Kobayashi K, Tadachi M, Kobayashi S, Inada Y, Kobayashi M, et al. Expressions and mechanical functions of alpha1-adrenoceptor subtypes in hamster ureter. Eur J Pharmacol 2007; 573:201-5. PMID: 17658513
22. Morita T, Wada I, Suzuki T, Tsuchida S. Characterization of alpha-adrenoceptor subtypes involved in regulation of ureteral fluid transport. Tohoku J Exp Med 1987; 152:111-8. PMID: 2820080
23. Vicentini FC, Mazzucchi E, Brito AH, Chedid Neto EA, Danilovic A, Srougi M. Adjuvant tamsulosin or nifedipine after extracorporeal shock wave lithotripsy for renal stones: a double blind, randomized, placebo-controlled trial. Urology 2011; 78:1016-21. doi: 10.1016/j.urology.2011.04.062 PMID: 21802124
24. Hussein MM. Does tamsulosin increase stone clearance after shockwave lithotripsy of renal stones? A prospective, randomized controlled study. Scand J Urol Nephrol 2010; 44:27-31. doi: 10.3109/00365590903359916 PMID: 19947900
25. John TT, Razdan S. Adjunctive tamsulosin improves stone free rate after ureteroscopic lithotripsy of large renal and ureteric calculi: a prospective randomized study. Urology 2010; 75:1040-2. doi: 10.1016/j.urology.2009.07.1257 PMID: 19819530
26. Heran BS, Galm BP, Wright JM. Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Database Syst Rev 2012; 8:CD004643. doi: 10.1002/14651858.CD004643.pub3 PMID: 22895943
27. Milani S, Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int 2005; 95 Suppl 4:29-36. PMID: 15871733
28. Liu CC, Huang SP, Wu WJ, Chou YH, Juo SH, Tsai LY, et al. The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis. Ann Epidemiol 2009; 19:539-45. doi: 10.1016/j.annepidem.2009.02.006 PMID: 19375945